Navigation Links
Par Pharmaceutical's Karen O'Connor Receives 2013 Cardinal Health Supply Chain Excellence Award
Date:10/24/2013

WOODCLIFF LAKE, N.J., Oct. 24, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. is proud to announce that Karen O'Connor, vice president, national accounts, has received the generic pharmaceutical manufacturer 2013 Cardinal Health Supply Chain Excellence Award.  The award was presented today at Cardinal's annual Business Partners Conference in Columbus, Ohio. 

The Cardinal Health Supply Chain Excellence Award recipient is judged across a variety of metrics specifically targeted at the importance of Cardinal's generic pharmaceutical manufacturer partners.  These metrics recognize actions taken by generic suppliers to enhance service levels and create efficiencies in the supply chain, including execution on new product launches. 

"It is especially gratifying to receive an award from a highly-valued strategic partner," said Renee Kenney, senior vice president generic sales for Par Pharmaceutical.  "Both Karen and Par are honored to be recognized by Cardinal Health for our unwavering commitment to customer service.  Our efforts underscore the importance of this partnership to Par and we are proud of the trust and confidence that Cardinal has placed in us." 

Ms. O'Connor has been responsible for managing the company's relationship with Cardinal Health since joining Par in 2007.  

About Par Pharmaceutical Companies, Inc.  
Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals.  For press release and other company information, visit www.parpharm.com

 


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2a Cellulite Study of Collegenase Clostridium Histolyticum
2. Avanir Pharmaceuticals to Host Investor Day on October 29, 2013
3. CoLucid Pharmaceuticals and ILDONG Pharmaceutical Enter into a Distribution and Supply Agreement for Lasmiditan, a Novel Agent for Acute Migraine
4. Jazz Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 5, 2013
5. Norwich Pharmaceuticals is now Norwich Pharma Services
6. Hanmi Pharmaceuticals to Assign the Rights to Five New Territories to Kinex as Part of the Orascovery Program Strategic Plan
7. Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinsons Disease
8. AcelRx Pharmaceuticals to Hold Third Quarter 2013 Financial Results Conference Call and Webcast on November 5, 2013
9. Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013
10. Global Strategic Business Radiopharmaceuticals Report 2013-2018: High Costs of Drug Development Piques Manufacturers
11. DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Potential Treatment for Three Chemotherapy Resistant Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Feb. 22, 2017 The Senior Care Pharmacy ... Senate and House of Representatives that will curtail the ... (PBMs) -- from extracting retroactive direct and indirect remuneration ... (LTC) pharmacies and the Medicare program. S. ... (R-WV) and Jon Tester (D-MT), and House ...
(Date:2/22/2017)... DUBLIN , Feb 22, 2017 Research ... Devices Market Analysis & Trends - Industry Forecast to 2025" report ... The ... of around 5.2% over the next decade to reach approximately $2.1 billion ... estimates and forecasts for all the given segments on global as well ...
(Date:2/22/2017)... 2017 Henry Schein Medical today announced ... with Rijuven, which develops innovative digital medical devices, ... practitioners. CardioSleeve is a stethoscope ... sound signals, transmits real-time data to any smartphone ... to help physicians provide diagnostic interpretation of a ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... 22, 2017 , ... A cylindrical “pipeline” used for treating ... reach ones, according to the results of a clinical trial announced Wednesday. , ... Ricardo A. Hanel, MD, PhD, neurovascular surgeon with Baptist Health and Lyerly Neurosurgery ...
(Date:2/22/2017)... ... 22, 2017 , ... Using the power of the internet, IdrisArkette.com has managed ... a period of just 24 months, thousands of individuals interested in a medical procedure ... , “The internet is not getting quieter. In fact it’s becoming noisier by the ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... of issues related to spine practices, is featuring Michigan neurosurgeon Jay Jagannathan, M.D., ... as one of a small number of neurosurgeons in Michigan performing minimally invasive ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five ... of those report that family members or friends have also commented about their ... hearing loss wear hearing aids. One reason, suggested by 89 percent of American ...
(Date:2/22/2017)... ... ... Social media marketing is transitioning from a singular person activity to a ... into this insight and more in its latest episode of its Brains Over Brawn ... with social media strategist and partner of the digital firm Med|Ed Digital Jessica Columbo. ...
Breaking Medicine News(10 mins):